Ryuya Yamanaka

4.6k total citations
110 papers, 3.5k citations indexed

About

Ryuya Yamanaka is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Ryuya Yamanaka has authored 110 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 35 papers in Immunology and 31 papers in Neurology. Recurrent topics in Ryuya Yamanaka's work include Glioma Diagnosis and Treatment (28 papers), Immunotherapy and Immune Responses (25 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). Ryuya Yamanaka is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Immunotherapy and Immune Responses (25 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). Ryuya Yamanaka collaborates with scholars based in Japan, United States and United Kingdom. Ryuya Yamanaka's co-authors include Azusa Hayano, Ryuichi Tanaka, Kleanthis G. Xanthopoulos, Naoki Yajima, Naoto Tsuchiya, Masakazu Sano, Yasuo Takashima, Jumpei Homma, Julie Lekstrom-Himes and Tsutomu Kobayashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ryuya Yamanaka

109 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuya Yamanaka Japan 32 1.4k 1.3k 1.1k 806 444 110 3.5k
Mahua Dey United States 29 1.5k 1.0× 1.0k 0.8× 1.5k 1.3× 1.3k 1.6× 346 0.8× 76 3.6k
D. Wade Clapp United States 29 856 0.6× 1.2k 0.9× 794 0.7× 380 0.5× 400 0.9× 64 3.1k
Sara M. Bodner United States 18 915 0.6× 1.6k 1.2× 2.1k 1.9× 445 0.6× 129 0.3× 27 3.9k
Finbarr E. Cotter United Kingdom 38 792 0.6× 2.6k 2.0× 1.3k 1.1× 872 1.1× 235 0.5× 111 5.0k
Marco Forni Italy 30 604 0.4× 813 0.6× 533 0.5× 256 0.3× 302 0.7× 93 2.5k
Scott Cooper United States 35 1.9k 1.4× 1.5k 1.1× 1.4k 1.2× 996 1.2× 72 0.2× 97 5.1k
Maria Carla Bosco Italy 32 1.7k 1.2× 1.1k 0.8× 770 0.7× 255 0.3× 162 0.4× 81 3.3k
Rafael Espinosa United States 35 916 0.6× 2.7k 2.0× 559 0.5× 386 0.5× 142 0.3× 67 4.9k
Stephen J. Brandt United States 28 849 0.6× 2.0k 1.5× 1.0k 0.9× 313 0.4× 93 0.2× 71 4.3k
Hitoshi Kohsaka Japan 36 1.5k 1.1× 1.2k 0.9× 586 0.5× 258 0.3× 106 0.2× 158 4.0k

Countries citing papers authored by Ryuya Yamanaka

Since Specialization
Citations

This map shows the geographic impact of Ryuya Yamanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuya Yamanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuya Yamanaka more than expected).

Fields of papers citing papers by Ryuya Yamanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuya Yamanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuya Yamanaka. The network helps show where Ryuya Yamanaka may publish in the future.

Co-authorship network of co-authors of Ryuya Yamanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuya Yamanaka. A scholar is included among the top collaborators of Ryuya Yamanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuya Yamanaka. Ryuya Yamanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takashima, Yasuo, Atsushi Kawaguchi, Yasuo Iwadate, et al.. (2019). MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS ONE. 14(1). e0210400–e0210400. 24 indexed citations
3.
Yamamoto, Yōko, et al.. (2017). Effects and safety of mechanical bathing as a complementary therapy for terminal stage cancer patients from the physiological and psychological perspective: a pilot study. Japanese Journal of Clinical Oncology. 47(11). 1066–1072. 9 indexed citations
4.
5.
Iwadate, Yasuo, Akiko Suganami, Shiro Ikegami, et al.. (2014). Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature. Journal of Neuro-Oncology. 117(2). 261–268. 15 indexed citations
6.
Kawaguchi, Atsushi, Yasuo Iwadate, Yoshihiro Komohara, et al.. (2012). Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma. Clinical Cancer Research. 18(20). 5672–5681. 36 indexed citations
7.
Yamanaka, Ryuya. (2009). Medical management of brain metastases from lung cancer (Review). Oncology Reports. 22(6). 1269–76. 48 indexed citations
8.
Yamanaka, Ryuya. (2009). Management of refractory or relapsed primary central nervous system lymphoma (Review). Molecular Medicine Reports. 2(6). 879–85. 6 indexed citations
9.
Fukai, Junya, Hideyuki Yokote, Ryuya Yamanaka, et al.. (2008). EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Molecular Cancer Therapeutics. 7(9). 2768–2778. 113 indexed citations
10.
Komohara, Yoshihiro, Shigeki Shichijo, Mamoru Harada, et al.. (2008). Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients. Oncology Reports. 19(5). 1277–83. 15 indexed citations
11.
Yamanaka, Ryuya, Ken Morii, Yoko Shinbo, et al.. (2008). Results of Treatment of 112 Cases of Primary CNS Lymphoma. Japanese Journal of Clinical Oncology. 38(5). 373–380. 17 indexed citations
12.
Yamanaka, Ryuya & Kleanthis G. Xanthopoulos. (2005). Induction of Antigen-Specific Immune Responses Against Malignant Brain Tumors by Intramuscular Injection of Sindbis DNA Encoding Gp100 and IL-18. DNA and Cell Biology. 24(5). 317–324. 30 indexed citations
13.
Yamanaka, Ryuya & Kleanthis G. Xanthopoulos. (2004). Development of Improved Sindbis Virus-Based DNA Expression Vector. DNA and Cell Biology. 23(2). 75–80. 12 indexed citations
14.
Yamanaka, Ryuya, et al.. (2003). CCAAT/enhancer binding proteins are expressed in the gerbil hippocampus after transient forebrain ischemia. Neuroscience Letters. 337(2). 106–110. 11 indexed citations
15.
Yamanaka, Ryuya, et al.. (2001). Ostip2, a Novel Oncoprotein that Associates with the Rho Exchange Factor Ost. DNA and Cell Biology. 20(7). 383–390. 1 indexed citations
16.
17.
Antonson, Per, Birgitta Stellan, Ryuya Yamanaka, & Kleanthis G. Xanthopoulos. (1996). A Novel Human CCAAT/Enhancer Binding Protein Gene, C/EBPϵ, Is Expressed in Cells of Lymphoid and Myeloid Lineages and Is Localized on Chromosome 14q11.2 Close to the T-Cell Receptor α/δ Locus. Genomics. 35(1). 30–38. 95 indexed citations
18.
Yamanaka, Ryuya, et al.. (1993). Effects of ACNU and Cranial Irradiation on the Mouse Immune System. Neurologia medico-chirurgica. 33(2). 65–70. 6 indexed citations
19.
Yamanaka, Ryuya & Susumu Satoh. (1989). Cerebral Blood Flow in Patients with Putaminal Hemorrhage after Stereotactic Aspiration or Conservative Treatment. Neurologia medico-chirurgica. 29(1). 15–19. 3 indexed citations
20.
Yamanaka, Ryuya, et al.. (1988). Analysis of rebleeding cases intra or post stereotactic hematoma aspiration.. Nosotchu. 10(1). 54–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahua Dey Breakdown of academic impact, for papers by D. Wade Clapp Breakdown of academic impact, for papers by Sara M. Bodner Breakdown of academic impact, for papers by Finbarr E. Cotter Breakdown of academic impact, for papers by Marco Forni Breakdown of academic impact, for papers by Scott Cooper Breakdown of academic impact, for papers by Maria Carla Bosco Breakdown of academic impact, for papers by Rafael Espinosa Breakdown of academic impact, for papers by Stephen J. Brandt Breakdown of academic impact, for papers by Hitoshi Kohsaka
Rankless by CCL
2026